Active 0 6 0 6 B-chronic_disease
chronic 7 14 7 14 I-chronic_disease
infection 15 24 15 24 I-chronic_disease
such 25 29 25 29 O
as 30 32 30 32 O
hepatitis 33 42 33 42 B-chronic_disease
B 43 44 43 44 I-chronic_disease
or 45 47 45 47 I-chronic_disease
C 48 49 48 49 I-chronic_disease
or 50 52 50 52 O
an 53 55 53 55 O
active 56 62 56 62 O
malignancy 63 73 63 73 B-cancer
that 74 78 74 78 O
requires 79 87 79 87 O
systemic 88 96 88 96 B-treatment
chemotherapy 97 109 97 109 I-treatment

Documentation 0 13 110 123 O
of 14 16 124 126 O
HIV-1 17 22 127 132 B-chronic_disease
infection 23 32 133 142 I-chronic_disease
defined 33 40 143 150 O
as 41 43 151 153 O
a 44 45 154 155 O
positive 46 54 156 164 O
antibody 55 63 165 173 O
test 64 68 174 178 O
or 69 71 179 181 O
plasma 72 78 182 188 O
HIV-1 79 84 189 194 O
RNA 85 88 195 198 O
( 89 90 199 200 O
ribosomal 90 99 200 209 O
ribonucleic 100 111 210 221 O
acid 112 116 222 226 O
) 116 117 226 227 O

Documentation 0 13 228 241 O
of 14 16 242 244 O
a 17 18 245 246 O
negative 19 27 247 255 O
HIV-1 28 33 256 261 B-chronic_disease
antibody 34 42 262 270 O
test 43 47 271 275 O

HIV 0 3 276 279 B-chronic_disease
- 3 4 279 280 O
infected 4 12 280 288 O
cohort 13 19 289 295 O
( 20 21 296 297 O
Cohort 21 27 297 303 O
A 28 29 304 305 O
) 29 30 305 306 O

HIV 0 3 307 310 B-chronic_disease
- 3 4 310 311 O
negative 4 12 311 319 O
cohorts 13 20 320 327 O
( 21 22 328 329 O
Cohort 22 28 329 335 O
B 29 30 336 337 O
and 31 34 338 341 O
C 35 36 342 343 O
) 36 37 343 344 O

Negative 0 8 345 353 O
pregnancy 9 18 354 363 O
test 19 23 364 368 O
( 24 25 369 370 O
if 25 27 370 372 O
female 28 34 373 379 B-gender
) 34 35 379 380 O

Plasma 0 6 381 387 B-clinical_variable
HIV-1 7 12 388 393 I-clinical_variable
RNA 13 16 394 397 I-clinical_variable
â‰¤ 17 18 398 399 O
50 19 21 400 402 B-upper_bound
copies 22 28 403 409 I-upper_bound
/ 28 29 409 410 I-upper_bound
mL 29 31 410 412 I-upper_bound
in 32 34 413 415 O
the 35 38 416 419 O
preceding 39 48 420 429 O
6 49 50 430 431 O
months 51 57 432 438 O

Treated 0 7 439 446 O
with 8 12 447 451 O
ART 13 16 452 455 B-treatment
( 17 18 456 457 O
minimum 18 25 457 464 O
of 26 28 465 467 O
three 29 34 468 473 B-lower_bound
antiretroviral 35 49 474 488 B-treatment
drugs 50 55 489 494 I-treatment
in 56 58 495 497 O
regimen 59 66 498 505 O
) 66 67 505 506 O
for 68 71 507 510 O
at 72 74 511 513 O
least 75 80 514 519 O
12 81 83 520 522 B-lower_bound
months 84 90 523 529 I-lower_bound
with 91 95 530 534 O
no 96 98 535 537 O
changes 99 106 538 545 O
in 107 109 546 548 O
antiretroviral 110 124 549 563 O
drugs 125 130 564 569 O
over 131 135 570 574 O
the 136 139 575 578 O
past 140 144 579 583 B-upper_bound
6 145 146 584 585 I-upper_bound
months 147 153 586 592 I-upper_bound

Use 0 3 593 596 O
of 4 6 597 599 O
systemic 7 15 600 608 B-treatment
( 16 17 609 610 I-treatment
oral 17 21 610 614 I-treatment
or 22 24 615 617 I-treatment
parenteral 25 35 618 628 I-treatment
) 35 36 628 629 I-treatment
antibiotics 37 48 630 641 I-treatment
within 49 55 642 648 O
two 56 59 649 652 B-upper_bound
months 60 66 653 659 I-upper_bound
prior 67 72 660 665 I-upper_bound
to 73 75 666 668 O
study 76 81 669 674 O
entry 82 87 675 680 O

